The P2Y12 receptor antagonist clopidogrel blocks platelet aggregation, improves systemic endothelial nitric oxide bioavailability, and has anti-inflammatory effects. Since P2Y12 receptors have been identified in the vasculature, we hypothesized that clopidogrel ameliorates angiotensin II (Ang II) -induced vascular functional changes by blockade of P2Y12 receptors in the vasculature. Male Sprague Dawley rats were infused with Ang II (60 ng.min-1) or vehicle for 14 days. The animals were treated with clopidogrel (10mg•kg-1•day-1) or vehicle. Vascular reactivity was evaluated in second-order mesenteric arteries. Clopidogrel treatment did not change systolic blood pressure [(mmHg) control-vehicle, 117±7.1 vs. control- Clopidogrel, 125±4.2; AngII-vehicle, 197±10.7 vs. AngII-Clopidogrel, 198±5.2], but it normalized increased phenylephrine-induced vascular contractions [(%KCl) vehicle-treated, 182.2±18 vs. Clopidogrel, 133±14%), as well as impaired vasodilation to acetylcholine [(%) vehicle-treated, 71.7±2.2 vs. Clopidogrel, 85.3±2.8) in Ang II-treated animals. Vascular expression of P2Y12 receptor was determined by western blot. Pharmacological characterization of vascular P2Y12 was performed with the P2Y12 agonist 2-MeS-ADP. Although 2-MeSADP induced endothelium-dependent relaxation [(Emax %) = 71%±12), as well as contractile vascular responses (Emax %= 83±12) these actions are not mediated by P2Y12 receptor activation. 2-MeS-ADP produced similar vascular responses in control and Ang II rats. These results indicate potential effects of Clopidogrel, such as improvement of hypertension-related vascular functional changes that are not associated with direct actions of clopidogrel in the vasculature, supporting the concept that activated platelets contribute to endothelial dysfunction, possibly via impaired NO bioavailability.
More here:
Clopidogrel, independent of vascular P2Y12 receptor, improves the arterial function in small mesenteric arteries from Ang II-hypertensive rats
Gagner de l’argent
Tags: sprague-dawley, sub, the-vasculature, vasculature
Related posts:
- Obesity is the major contributor to vascular dysfunction and inflammation in high fat diet hypertensive rats
- Clopidogrel application: beyond coronary artery disease
- Simultaneous inhibition of TxA2 and PGI2 synthesis increases NO release in mesenteric resistance arteries from cirrhotic rats
- Glycyrrhetic acid attenuates vascular smooth muscle vasodilatory function in healthy humans
- ACE2-angiotensin-(1-7)-Mas axis in renal ischemia/reperfusion injury in rats
Related posts brought to you by Yet Another Related Posts Plugin.
